Diagnostic yield of colonoscopy in Lynch Syndrome
We demonstrate a high adenoma burden with distinct phenotypic and gene-specific characteristics in a UK LS population undergoing high quality surveillance
fg.bmj.com/content/earl...
We’re proud to present the current Council members of The International Society for Gastrointestinal Hereditary Tumours (InSiGHT), driving progress in research, collaboration, and patient care worldwide.
Learn more about us👉 shorturl.at/6cyJV
#Genetics #GIHealth #HereditaryGICancer #InSiGHT
November is Pancreatic Cancer Awareness Month 💜
It’s the deadliest of the common cancers due to late detection.
Researchers stress genetic testing - hereditary risk matters. Know your family history. Advocate for early detection. 💜
Read more 👉 shorturl.at/eKuTB
#PancreaticCancer #GeneticTesting
I'm sure you did more than okay. I'm sure you were brilliant! I'm in awe of your incredible advocacy Tony. You've always been a powerful and consistent voice for prostate cancer awareness and support 😊👏
I am constantly bouncing from imminent death to endless life (mostly metaphorically, but sometimes literally) and the push and pull of it is exhausting.
www.medicalindependent.ie/comment/opin...
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
Confirmed great data from #8HW trial at #ESMO25 with the combination NIVO+IPI confirms the standard of care option in 1st line MSI-H/dMMR mCRC patients @oncodaily.bsky.social
And I'll bet you smashed it, Tony! You're a powerhouse 💙💪
Delighted with my presentation at #ESMO25 for @Medscape. It’s such a privilege to be given the patient voice and make the voices of the thousands of men that @TackleProstate support, heard. Now though I found a beer garden! Won’t be here long cos it’s freezing!
#ESMO25: Clinically relevant survival benefits reported in platinum-resistant #OvarianCancer with pembrolizumab plus weekly paclitaxel with or without bevacizumab in ENGOT-ov65/KEYNOTE-B96 #ESMODailyReporter 👉https://ow.ly/MIjA50XeuR3
#immunotherapy
#ESMO25 Wonderful to see so many ☘️ colleagues at @myesmo.bsky.social #ClimateChange task force meeting
Encouraging to see such interest in 🌍 Sustainability 🌳
@cancertrialsie.bsky.social @irishdocsenv.bsky.social
#ESMO25: Regular exercise has a significant impact on patient survival, but how can physical activity be integrated into the patient journey? Pr Michel Ducreux considers barriers and possible solutions.
#ESMODailyReporter📌 https://ow.ly/zect50Xezeq
#CancerCare #CancerManagement
Powerful message from Dr Anne-Marie Baird (TCD, ILCC) at #ESMO25 on gender bias in cancer care:
🔍 Recognise – bias distorts outcomes
🔧 Redesign – integrate sex & gender in every step
📊 Report – transparency in data, trials & diagnostics
#CancerEquity #PatientAdvocacy #LungCancer
🗞️ Check out my short #ESMODailyReporter editorial on early data from a first-in-human TCR-T therapy targeting KRAS G12V in advanced pancreatic & colorectal cancer, presented today by Dr Bai from Zhejiang University.
#ESMO25
#CellTherapy
#ESMOAmbassadors
@myesmo.bsky.social
#ESMO25: Are personalised #CancerVaccines the next frontier or an elusive goal? Catherine Wu discusses the exciting potential of genomics-guided personalised vaccines and some of the related challenges.
#ESMODailyReporter 👉 https://ow.ly/aMxi50Xgn37
#ImmunoOncology
🧬 October = National Family History Month!
Read the blog📜👉 tinyurl.com/bdhjjv83
Reminding us that even in the era of🧬testing, 👪history is still the foundation of hereditary cancer care. Asking the right❓& sharing results can save lives across generations.
#HereditaryGICancer
📣Missed #CGAIGC25 this year?
Catch the short discussion between Prof Sir John Burn & @swatipatelmd.bsky.social sharing long-awaited CaPP3 results, a follow-up to the landmark CaPP2 trial showing aspirin’s 💊role in lowering cancer risk in #LynchSyndrome
👉 tinyurl.com/msshdb5b
#HereditaryGICancer
Congratulations to our UCAN Ireland members @miriamstaunton.bsky.social & @cynthiacravo.bsky.social on becoming EUPATI Fellows 🎉
A wonderful achievement and testament of your dedication to patient advocacy👏👏👏
#ExpertPatientVoices #CancerTherapeutics #Innovation #EUPATI
The Irish Cancer Society has said there is a complacent notion that Ireland is doing well in terms of cancer treatment.
September is #OvarianCancer Awareness Month, a time to spotlight a disease that remains one of the deadliest gynecologic cancers. In 2025, > 20,000 women in the U.S. will be diagnosed with OVCA, and roughly 60% of those diagnosed will die from it!
#gyncsm #womenshealth #medsky #hereditarycancer
Having reliable access to safe, affordable medicines 💊 is essential for everyone.
We are urging policymakers to prioritise these issues and encourage manufacturers to produce the medicines in demand.
➡️ www.sandoz.com/makingaccess...
#AccessToMedicines #HealthEquity @helloeacr.bsky.social
